Lukes, J., Winkowska, L., Zwyrtkova, M., Starkova, J., Sramkova, L., Stary, J., . . . Zaliova, M. (2020). Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1. Hemasphere.

Lukes, Julius, Lucie Winkowska, Martina Zwyrtkova, Julia Starkova, Lucie Sramkova, Jan Stary, Jan Trka, Jan Zuna, and Marketa Zaliova. "Identification of Fusion Gene Breakpoints Is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring On Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1." Hemasphere 2020.

Lukes, Julius, et al. "Identification of Fusion Gene Breakpoints Is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring On Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1." Hemasphere 2020.